GlassScriptPhysician profile
Jesse N Mills
NPI 1295881803
$259,350.78
in general payments reported to CMS, 2019-2025
17 companies · $13K in 2025
The $13K reported for 2025 was more than what 95% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76K · 2020: $23K · 2021: $55K · 2022: $30K · 2023: $36K · 2024: $26K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $37K · Honoraria: $14K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $6,878 · Travel and Lodging: $6,719.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $36,640.00 |
| Honoraria | $13,500.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,550.00 |
| Food and Beverage | $6,878.34 |
| Travel and Lodging | $6,718.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $99,313.31 | 2019-2025 | General - Erectile Dysfunction, Ams 700, General - Therapies |
| Endo Pharmaceuticals INC. | $98,111.45 | 2019-2024 | Xiaflex |
| Antares Pharma, INC. | $35,232.78 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Endo USA, INC. | $22,779.57 | 2024-2025 | Xiaflex, Aveed, Edex |
| Metuchen Pharmaceuticals | $1,711.08 | 2019-2020 | |
| Verity Pharmaceuticals INC. | $1,117.27 | 2024-2025 | Tlando |
| C. R. Bard, INC. & Subsidiaries | $289.51 | 2023-2025 | Bard Urinary Drainage Bag, Magic3 Go Intermittent Urinary Catheter |
| Rochester Medical Corporation | $277.51 | 2021-2022 | |
| Coloplast Corp | $134.79 | 2020-2021 | |
| Halozyme INC | $92.79 | 2023 | |
| Abbvie INC. | $91.23 | 2022 | |
| Becton, Dickinson and Company | $65.10 | 2023-2024 | Bard Urinary Drainage Bag |
| Baxter Healthcare | $55.97 | 2024 | Tisseel |
| Teleflex LLC | $37.10 | 2025 | Barrigel |
| Urogen Pharma, INC. | $16.71 | 2023 | Jelmyto |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $13.28 | 2021 | |
| Clarus Therapeutics INC. | $11.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Mills listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.